Taguchi, Akira http://orcid.org/0000-0003-2620-1487
,
Uemura, Yukari
Imai, Takumi
Tanaka, Shiro
Ohta, Hiroaki
Nakamura, Toshitaka
Orimo, Hajime
Sugimoto, Toshitsugu
Soen, Satoshi
Shiraki, Masataka
Funding for this research was provided by:
Japan Agency for Medical Research and Development (17lk0201061h0002)
Article History
Received: 8 December 2018
Accepted: 21 January 2019
First Online: 4 February 2019
Compliance with ethical standards
:
: AT received consultancy or lecture fees from Asahikasei Pharmaceutical Co., Teijin Pharma, Ono Pharmaceutical Co., Chugai Pharmaceutical Co., Takeda Pharmaceutical Co., and Daiichi Sankyo Co. YU received a consultancy fee from Teijin Pharma. ST has received lecture fees from Astra-Zeneca, Taiho, and Ono Pharmaceutical Co. He has received consultation fees from DeNA Life Science and CanBus. He has received outsourcing fees from Satt and Asahi Kasei Pharma. His wife has been engaged in a research project for Bayer. HO received fees from Pfizer Japan Inc. TS has received research grants from Astellas Pharma, Eisai, Daiichi Sankyo, Chugai Pharmaceutical, and Eli Lilly Japan as well as consulting and/or lecture fees from Asahi Kasei Pharma and Daiichi Sankyo. SS received lecture and consultancy fees from Asahikasei Pharmaceutical Co., Astellas Pharma, Chugai Pharmaceutical Co., Daiichi Sankyo Co., Eisai Co., Eli Lilly Japan, Ono Pharmaceutical Co., Pfizer Co., and Takeda Pharmaceutical Co. MS received lecture and consultancy fees from Asahikasei Pharma and Teijin Pharma. TI, TN, and HO declare that they have no conflict of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.